Showing results (1-10 of 3,564) with videos related to

Sort By:
Pageof 357
Archives of Pharmacal Research|March 11, 1999
Development of TGF-beta resistance during malignant progressionY S Kim, Y Yi, S G Choi, et al.
Oncogene|January 25, 2000
Over-expression of ERT(ESX/ESE-1/ELF3), an ets-related transcription factor, induces endogenous TGF-beta type II receptor expression and restores the TGF-beta signaling pathway in Hs578t human breast cancer cellsJ Chang, C Lee, K B Hahm, et al.
The Journal of Biological Chemistry|February 7, 1998
A novel ets-related transcription factor, ERT/ESX/ESE-1, regulates expression of the transforming growth factor-beta type II receptorS G Choi, Y Yi, Y S Kim, et al.
Clinical Radiology|July 15, 2021
Diagnostic test accuracy of 18F-FDG PET/CT for prediction of programmed death ligand 1 (PD-L1) expression in solid tumours: a meta-analysisH Y Seol, Y S Kim, S-J Kim
Cancer|May 15, 1997
Detection of epidermal growth factor receptor in the serum of gastric carcinoma patientsJ H Choi, J Y Oh, S K Ryu, et al.
Oncogene|April 21, 2001
Sequence-specific enhancer binding protein is responsible for the differential expression of ERT/ESX/ELF-3/ESE-1/jen gene in human gastric cancer cell lines: Implication for the loss of TGF-beta type II receptor expressionS H Park, Y S Kim, B K Park, et al.
Genes & Development|March 7, 2001
The hepatitis B virus encoded oncoprotein pX amplifies TGF-beta family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosisD K Lee, S H Park, Y Yi, et al.
Neoplasma|January 20, 2009
Characterization of pulmonary lesions with low F-18 FDG uptake using double phase F-18 FDG PET/CT: comparison of visual and quantitative analysesI J Kim, S J Kim, Y S Kim, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 11, 2006
An interaction between the serotonin transporter promoter region and dopamine transporter polymorphisms contributes to harm avoidance and reward dependence traits in normal healthy subjectsS J Kim, Y S Kim, H S Lee, et al.
Transplantation Proceedings|February 8, 2012
A 6-month, open-label, multicenter clinical study in Korean de novo renal transplant patients evaluating the efficacy, safety, and tolerance of myfortic concomitantly used with tacrolimusM K Ju, S H Park, S J Kim, et al.
Pageof 357